2Cunningham D,Starling N,Rao S,et al.Capecitabine and oxalipla-tin for advanced esophagogastric cancer. The New England Journal of Medicine . 2008
3Luo HY,Xu RH,Zhang L,et al.A pilot study of oxaliplatin,flu-orouracil and folinic acid (FOLFOX-6)as first-line chemo-therapy in advanced or recurrent gastric cancer. Chemothera-py . 2008
4Ahmedin JD,Freddie Bray,Melissa MC,et al.Global Cancer Statistics. CA A Cancer Journal for Clinicians . 2011
5Kang Y,Kang WK,Shin DB,et al.Randomized phase III trial ofcapecitabine/cisplatin (XP)vs.continuous infusion of 5-FU/cis-platin (FP)as first-line therapy in patients (pts)with advancedgastric cancer (AGC):efficacy and safety results. Journal of Clinical Oncology . 2006
6Pyrhonen S,Kuitunen T,Nyandoto P,et al.Randomized comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. British Journal of Cancer . 1995
7Murad AM,Santiago FF,Petroianu A,et al.Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer. Cancer . 1993
8Ohtsu A,Shimada Y,Shirao K,et al.Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205). Journal of Clinical Oncology . 2003
9Vanhofer U,Rougier P,Wilke H,et al.Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: a trial of the Europe. Journal of Clinical Oncology . 2000
